OBLN: Obalon Therapeutics, Inc. - Summary | Jitta

Obalon Therapeutics, Inc.

NASDAQ:OBLN

Notice
Stock data is unavailable or the company’s delisted.
Price
$9.15
Loss Chance
58.4%
0.05JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (23)
Recent Business Performance (39)
Financial Strength (32)
Return to Shareholders (0)
Competitive Advantage (4)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2020
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
0.05
100.00%
3.06
202.87%
Health Care Equipment
6.77
32.24%
0.01
100.00%
5.52
256.09%
COMPANY DESCRIPTION
As of June 15, 2021, Obalon Therapeutics, Inc. was acquired by ReShape Lifesciences Inc., in a reverse merger transaction. Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.